{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T01:32:35Z","timestamp":1773279155237,"version":"3.50.1"},"reference-count":30,"publisher":"Japanese Pharmacological Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Pharmacol Sci"],"published-print":{"date-parts":[[2008]]},"DOI":"10.1254\/jphs.fp0071943","type":"journal-article","created":{"date-parts":[[2008,2,22]],"date-time":"2008-02-22T05:50:41Z","timestamp":1203659441000},"page":"264-270","source":"Crossref","is-referenced-by-count":13,"title":["Inhibitory Effects of Ramosetron, a Potent and Selective 5-HT3\u2013Receptor Antagonist, on Conditioned Fear Stress\u2013Induced Abnormal Defecation and Normal Defecation in Rats: Comparative Studies With Antidiarrheal and Spasmolytic Agents"],"prefix":"10.1254","volume":"106","author":[{"given":"Takuya","family":"Hirata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiyuki","family":"Funatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Keto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinobu","family":"Akuzawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masao","family":"Sasamata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiji","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"332","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.11.060"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.11.061"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Brandt LJ, Bjorkman D, Fennerty MB, Locke GR, Olden K, Peterson W, et al. Systematic review on the management of irritable bowel syndrome in North America. Am J Gastroenterol. 2002;97 11 Suppl:S7&ndash;S26.","DOI":"10.1016\/S0002-9270(02)05657-5"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02033-X"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Caras S, Krause G, Biesheuvel E, Steinborn C. Cilansetron shows efficacy in male and female non-constipated patients with irritable bowel syndrome in a United States Study. Gastroenterology. 2001;120 Suppl 1:A217.","DOI":"10.1016\/S0016-5085(08)81078-5"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Crowell MD. Role of serotonin in the pathophysiology of the irritable bowel syndrome. Br J Pharmacol. 2004;141:1285&ndash;1293.","DOI":"10.1038\/sj.bjp.0705762"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Bearcroft CP, Perrett D, Farthing MJ. Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study. Gut. 1998;42:42&ndash;46.","DOI":"10.1136\/gut.42.1.42"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1254\/jjp.63.495"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1254\/jphs.FP0050353"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1254\/jphs.FP0070620"},{"issue":"2","key":"11","first-page":"815","volume":"259","year":"1991","ISSN":"https:\/\/id.crossref.org\/issn\/0022-3565","issn-type":"print"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Funatsu T, Takeuchi A, Hirata T, Keto Y, Akuzawa S, Sasamata M. Effect of ramosetron on conditioned emotional stress-induced colonic dysfunction as a model of irritable bowel syndrome in rats. Eur J Pharmacol. 2007;573:190&ndash;195.","DOI":"10.1016\/j.ejphar.2007.06.041"},{"issue":"1","key":"13","first-page":"297","volume":"261","year":"1992","ISSN":"https:\/\/id.crossref.org\/issn\/0022-3565","issn-type":"print"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(95)00830-6"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1007\/BF01296258"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Page JG, Dirnberger GM. Treatment of the irritable bowel syndrome with Bentyl (dicyclomine hydrochloride). J Clin Gastroenterol. 1981;3:153&ndash;156.","DOI":"10.1097\/00004836-198106000-00009"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Nakamura E, Imasaki H, Takeshige T, Miura H, Watanabe T, Higuchi S. [Metabolic fate of ramosetron hydrochloride (2): Absorption, distribution and excretion after oral administration of <sup>14<\/sup>C-ramosetron hydrochloride to rats]. Yakubutsudoutai. 1995;10:808&ndash;818. (text in Japanese with English abstract)","DOI":"10.2133\/dmpk.10.808"},{"issue":"9","key":"18","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1248\/cpb.44.1707","volume":"44","author":"OHTA M","year":"1996","ISSN":"https:\/\/id.crossref.org\/issn\/0009-2363","issn-type":"print"},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1254\/jjp.78.381"},{"key":"20","doi-asserted-by":"publisher","DOI":"10.1254\/jjp.65.241"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Li M, Johnson CP, Adams MB, Sarna SK. Cholinergic and nitrergic regulation of in vivo giant migrating contractions in rat colon. Am J Physiol-Gastroint Liver Physiol. 2002;283:G544&ndash;G552.","DOI":"10.1152\/ajpgi.00114.2001"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Shafik A, El-Sibai O, Ahmed I. Parasympathetic extrinsic reflex: role in defecation mechanism. World J Surg. 2002;26:737&ndash;740.","DOI":"10.1007\/s00268-002-6285-9"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Miyata K, Ito H, Fukudo S. Involvement of the 5-HT<sub>3<\/sub> receptor in CRH-induce defecation in rats. Am J Physiol-Gastroint Liver Physiol. 1998;274:G827&ndash;G831.","DOI":"10.1152\/ajpgi.1998.274.5.G827"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Hirata T, Funatsu T, Keto Y, Nakata M, Sasamata M. Pharmacological profile of ramosetron, a novel therapeutic agent for IBS. Inflammopharmacology. 2007;15:5&ndash;9.","DOI":"10.1007\/s10787-006-1537-1"},{"key":"25","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(99)00188-5"},{"key":"26","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2982.1998.00127.x"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Axelsson LG, Wallin B, Gillberg PG, Sjoberg B, Soderberg C, Hellstrom PM. Regulatory role of 5-HT and muscarinic receptor antagonists on the migrating myoelectric complex in rats. Eur J Pharmacol. 2003;467:211&ndash;218.","DOI":"10.1016\/S0014-2999(03)01637-6"},{"key":"28","doi-asserted-by":"publisher","DOI":"10.1007\/BF01295711"},{"issue":"5","key":"29","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.2042-7158.1987.tb03409.x","volume":"39","author":"Roman F, Pascaud X, Taylor JE and J","year":"1987","ISSN":"https:\/\/id.crossref.org\/issn\/0022-3573","issn-type":"print"},{"key":"30","doi-asserted-by":"publisher","DOI":"10.1254\/jjp.82.343"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T15:16:48Z","timestamp":1621437408000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/jphs\/106\/2\/106_FP0071943\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1254\/jphs.fp0071943","relation":{},"ISSN":["1347-8613","1347-8648"],"issn-type":[{"value":"1347-8613","type":"print"},{"value":"1347-8648","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008]]}}}